Article by Lalita Panicker, Consulting Editor, Views and Editor, Insight, Hindustan Times, New Delhi
Last year, the U.S. Food and Drug Administration approved two gene therapy procedures that can treat and, in some cases, essentially cure sickle cell disease. This...
Last week the United Kingdom became the first country to approve an updated COVID-19 booster directed at two different strains of the coronavirus. The “bivalent” booster, made by Moderna, will have the same dose of messenger RNA as the...
